摘要
目的探讨谷氨酰胺联合美洛昔康对重症急性胰腺炎(SAP)肠黏膜屏障损伤的保护作用及HGF因子、D-乳酸水平的影响。方法选取2008年8月—2017年8月我院收治的重症急性胰腺炎(SAP)患者86例作为研究对象。按数字表法,将其分为两组。两组患者均常规行营养治疗。对照组应用谷氨酰胺治疗,研究组联合应用美洛昔康治疗。比较两组患者的临床疗效。结果研究组腹痛消失时间及平均住院时长均低于对照组,差异具有统计学意义(P <0.05);治疗后,研究组各时间点下的血浆内毒素水平、HGF及D-乳酸水平均优于对照组,差异具有统计学意义(P <0.05)。结论 SAP患者应用谷氨酰胺联合美洛昔康疗效优于谷氨酰胺单用。
Objective To explore the protective effect of glutamine combined with meloxicam on intestinal mucosal barrier injury in severe acute pancreatitis(SAP) and the effect of HGF factor and D-lactic acid level. Methods A total of 86 patients with severe acute pancreatitis(SAP)admitted to our hospital from August 2008 to August 2017 were selected as the study subjects. According to the method of digital table, it is divided into two groups. Two groups of patients were routinely treated with nutrition.The control group was treated with glutamine. The study group was treated with meloxicam. The clinical effects of the two groups were compared.Results The disappearance time of abdominal pain and the average length of hospitalization in the study group were lower than those in the control group, and the difference was statistically significant(P < 0.05). After treatment, the plasma endotoxin level, HGF and D-lactic acid level of the study group were better than those of the control group at each time point,with statistical significance(P < 0.05). Conclusion The curative effect of Glutamine Combined with meloxicam in SAP patients is better than that of glutamine alone.
引文
[1]柏超,陈霞,李昌平.HMGB1在重症急性胰腺炎肠黏膜屏障损伤中作用的研究进展[J].山东医药,2016,56(34):103-105.
[2]游扬,杨歆,常杏,等.腺苷酸活化蛋白激酶在重症急性胰腺炎大鼠肠黏膜屏障损伤机制中的作用[J].第三军医大学学报,2016,38(9):975-981.
[3]蔡治方,兑丹华,兰天罡,等.清胰Ⅱ号制剂与谷氨酰胺对SAP大鼠肠黏膜屏障功能障碍影响的实验对比研究[J].重庆医学,2017,46(A02):155-156.
[4]Liu Z,Li L,Chen W,et al.Aryl hydrocarbon receptor activation maintained the intestinal epithelial barrier function through Notch1dependent signaling pathway[J].International Journal of Molecular Medicine,2018,41(3):1560-1572.
[5]张卫静.谷氨酰胺早期肠内营养与重组人生长激素联合治疗重症急性胰腺炎的疗效观察[J]解放军医学杂志,2017,42(5):480-482.
[6]朱文艺,杜珊珊,何佳霖,等.不同营养支持途径补充谷氨酰胺对重症急性胰腺炎患者血清蛋白水平的叠加效应[J].第三军医大学学报,2016,38(3):284-287.
[7]刘敏,张长城,顿耀艳.谷氨酰胺对肠道黏膜屏障功能保护作用的研究进展[J].广东医学,2016,37(22):3463-3465.
[8]丁学琨,刘艳丽,史一杰,等.美洛昔康肠道2次脉冲释药组合片的研制[J].中国新药杂志,2011,20(12):1141-1144.
[9]王盈.美洛昔康自纳米乳化颗粒的研制[J].中国医药工业杂志,2017,36(3):433.
[10]Majka G,Wi?cek G,?piewak K,et al.The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation[J].Biometals,2016,29(6):1019-1033.
[11]李培培,邰宇,黄传兵,等.美洛昔康片联合甲氨蝶呤片治疗类风湿关节炎的临床研究[J].中国临床药理学杂志,2016,32(22):2023-2026.
[12]连王权,申宝德,沈成英,等.美洛昔康口腔速溶膜的制备及体外释放特性[J].中国新药杂志,2017,19(20):2478-2484.
